Molecular alterations at 9q33.1 and polyploidy in asbestos-related lung cancer

Clinical Cancer Research

Volumn 15, Issue 2, 2009, Pages 468-475

  Nymark, Penny ^a,d   Kettunen, Eeva ^a   Aavikko, Mervi ^a   Ruosaari, Salla ^a,e   Kuosma, Eeva ^b   Vanhala, Esa ^c   Salmenkivi, Kaisa ^d   Pirinen, Risto ^f   Karjalainen, Antti ^b   Knuutila, Sakari ^d   Wikman, Harriet ^g   Anttila, Sisko ^a,c,d  

^a Health and Work Ability   (Finland)

^b Good Practices and Competence   (Finland)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e AALTO UNIVERSITY   (Finland)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

ADULT; ALLELIC IMBALANCE; ARTICLE; ASSOCIATION; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER RISK; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CIGARETTE SMOKING; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; OCCUPATIONAL EXPOSURE; POLYPLOIDY; PRIORITY JOURNAL;

AGED; ALLELES; ASBESTOS; CHROMOSOME ABERRATIONS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYPLOIDY;

EID: 59449100201     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1852     Document Type: Article

References (37)

1. LaDou J. The asbestos cancer epidemic. Environ Health Perspect 2004;112:285-90.
2. WHO. WHO calls for prevention of cancer through healthy workplaces. Geneva: World Health Organization; 2007.
3. Marczynski B, Czuppon A, Marek W, Reichel G, Baur X. Increased incidence of DNA double-strand breaks and anti-ds DNA antibodies in blood of workers occupationally exposed to asbestos. Hum Exp Toxicol 1994;13:3-9.
4. Fatma N, Jain A, Rahman Q. Frequency of sister chromatid exchange and chromosomal aberrations in asbestos cement workers. Br J Ind Med 1991;48: 103-5.
5. Suzuki M, Piao C, Zhao Y, Hei T. Karyotype analysis of tumorigenic human bronchial epithelial cells transformed by chrysolite asbestos using chemically induced premature chromosome condensation technique. Int J Mol Med 2001;8:43-7.
6. Dopp E, Schuler M, Schiffmann D, Eastmond D. A. Induction of micronuclei, hyperdiploidy and chromosomal breakage affecting the centric/pericentric regions of chromosomes 1 and 9 in human amniotic fluid cells after treatment with asbestos and ceramic fibers. Mutat Res1997;377:77-87.
7. Marsit CJ, Hasegawa M, Hirao T, et al. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer. Cancer Res 2004;64:8702-7.
8. Nymark P, Wikman H, Ruosaari S, et al. Identification of specific gene copy number changes in asbestos-related lung cancer. Cancer Res 2006;66: 5737-43.
9. Ruosaari S, Nymark P, Aavikko M, et al. Aberrations of chromosome 19 in asbestos-associated lung cancer and in asbestos-induced micronuclei of bronchial epithelial cells in vitro. Carcinogenesis 2008;29: 913-7.
10. Wikman H, Ruosaari S, Nymark P, et al. Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos- associated lung cancer. Oncogene 2007;26:4730-7.
11. Karjalainen A, Anttila S, Heikkila L, Karhunen P, Vainio H. Asbestos exposure among Finnish lung cancer patients: occupational history and fiber concentration in lung tissue. Am J Ind Med 1993:23:461 -71.
12. Karjalainen A, Anttila S, Vanhala E, Vainio H. Asbestos exposure and the risk of lung cancer in a general urban population. Scand J Work Environ Health 1994;20:243-50.
13. Churg A. Mineral analysis of the lung parenchyma. In: Crystal RG, Barnes PJ, editors. The lung: scientific foundations. Vol. 2. Philadelphia: Lippincott-Raven Pub; 1997. p. 2325-38.
14. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365-86.
15. Kettunen E, el-Rifai W, Bjorkqvist AM, et al. A broad amplification pattern at 3q in squamous cell lung cancer - a fluorescence in situ hybridization study. Cancer Genet Cytogenet 2000;117:66-70.
16. Andersen CL, Hostetter G, Grigoryan A, Sauter G, Kallioniemi A. Improved procedure for fluorescence in situ hybridization on tissue microarrays. Cytometry 2001;45:83-6.
17. Jensen C, Jensen L, Rieder C, Cole R, Ault J. Long crocidolite asbestos fibers cause polyploidy by sterically blocking cytokinesis. Carcinogenesis 1996;17: 2013-21.
18. Baudis M, Cleary ML Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 2001;17:1228-9.
19. Beau-Faller M, Gaub M, Schneider A, et al. Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients. Int J Cancer 2003; 105:361 -70.
20. Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF, Minna JD. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 2000;60: 4894-906.
21. Merlo A, Gabrielson E, Mabry M,Vollmer R, Baylin SB, Sidransky D. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res 1994;54:2322-6.
22. Kannio A, Ridanpaa M, Koskinen H, et al. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos. Cancer Epidemiol Biomarkers Prev 1996;5:33-9.
23. Ugnat A, Luo W, Semenciw R, Mao Y. Occupational exposure to chemical and petrochemical industries and bladder cancer risk in four western Canadian provinces. Chronic Dis Can 2004;25:7-15.
24. 1/S transition by the candidate bladder tumour suppressor gene DBCCR1. Oncogene 2001;20:2956-64.
25. Izumi H, Inoue J, Yokoi S, et al. Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non- small cell lung cancers. Hum Mol Genet 2005;14: 997-1007.
26. Knudson AJ. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971;68: 820-3.
27. Gao S, Worm J, Guldberg P, et al. Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma. Br J Cancer 2004;91:760-4.
28. Gronbak K, Ralfkiaer U, Dahl C, et al. Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms. Mod Pathol 2008;21:632-8.
29. Beetz C, Brodoehl S, Patt S, Kalff R, Deufel T. Low expression but infrequent genomic loss of the putative tumour suppressor DBCCR1 in astrocytoma. Oncol Rep 2005;13:335-40.
30. Björkqvist AM, Tammilehto L, Nordling S, et al. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br J Cancer 1998; 77:260-9.
31. Lindholm P, Salmenkivi K, Vauhkonen H, et al. Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH. Cytogenet Genome Res 2007;119:46-52.
32. Taniguchi T, Karnan S, Fukui T, et al. Genomic profiling of malignant pleural mesothelioma with array- based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32. Cancer Sci 2007;98:438-46.
33. Fauth E, Scherthan H, Zankl H. Chromosome painting reveals specific patterns of chromosome occurrence in mitomycin C- and diethylstilboestrol- induced micronuclei. Mutagenesis 2000;15:459-67.
34. Obe G, Pfeiffer P, Savage JRK, et al. Chromosomal aberrations: formation, identification and distribution. Mutat Res 2002;504:17-36.
35. Martinez-Lopez W, Di Tomaso MV. Chromatin remodelling and chromosome damage distribution. Human Exp Toxicol 2006;25:539-45.
36. Moore LE, Smith AH, Eng C, et al. Arsenic-related chromosomal alterations in bladder cancer. J Natl Cancer Inst 2002;94:1688-96.
37. Chien C, Chiang M, Ho I, Lee T. Association of chromosomal alterations with arsenite-induced tumorigenicity of human HaCaT keratinocytes in nude mice. Environ Health Perspect 2004;112:1704-10.